Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Alzheimer's: Second phase 3 study results for tau aggregation inhibitor

Science Daily - 28 Nov 2017 23:04
Full results from a second Phase 3 clinical study of LMTX®, the first tau aggregation inhibitor in Alzheimer's disease, has been released by researchers.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard